Stock BQST BIOQUEST CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials BioQuest Corp.

Equities

BQST

US09076H1023

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 19:57:12 07/05/2024 BST 		5-day change 1st Jan Change
0.0227 USD -82.54% Intraday chart for BioQuest Corp. -82.54% -98.83%
2022 BioQuest Corp. cancelled the acquisition of 49% stake in Progressus Clean Technologies Inc. from Powertap Hydrogen Capital Corp. (OTCPK:MOTN.F), T2M Global and Aberdeen International Inc.. CI
2022 BioQuest Corp. Reports Earnings Results for the First Quarter Ended July 31, 2022 CI

Valuation

Fiscal Period: Abril 2019 2020 2021 2022
Capitalization 1 3.064 217.2 8.731 5.881
Enterprise Value (EV) 1 3.064 217.2 8.805 6.031
P/E ratio -1,410 x -300 x -3.56 x -6.42 x
Yield - - - -
Capitalization / Revenue - - - -
EV / Revenue - - - -
EV / EBITDA - - - -
EV / FCF - - 11,992,979 x -3,376,368 x
FCF Yield - - 0% -0%
Price to Book -347 x -1,567 x -4.93 x -13.6 x
Nbr of stocks (in thousands) 102 8,044 8,731 11,310
Reference price 2 30.00 27.00 1.000 0.5200
Announcement Date 21/10/20 21/10/20 13/08/21 15/08/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Abril 2019 2020 2021 2022
Net sales - - - -
EBITDA - - - -
EBIT 1 -0.002175 -0.3566 -2.201 -0.8179
Operating Margin - - - -
Earnings before Tax (EBT) 1 -0.002175 -0.359 -2.324 -0.821
Net income 1 -0.002175 -0.359 -2.324 -0.821
Net margin - - - -
EPS 2 -0.0213 -0.0900 -0.2806 -0.0810
Free Cash Flow - - 0.728 -1.742
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 21/10/20 21/10/20 13/08/21 15/08/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: April 2019 2020 2021 2022
Net Debt - 0.04 0.07 0.15
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - 0.73 -1.74
ROE (net income / shareholders' equity) - 487% 244% 74.6%
ROA (Net income/ Total Assets) - - -15,935% -2,019%
Assets 1 - - 0.0146 0.0407
Book Value Per Share 2 -0.0900 -0.0200 -0.2000 -0.0400
Cash Flow per Share - 0 0 0
Capex - - - -
Capex / Sales - - - -
Announcement Date 21/10/20 21/10/20 13/08/21 15/08/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
BIOQUEST CORP. Stock BioQuest Corp.
-98.83% 261K
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+18.67% 43.74B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+23.52% 22.26B
SANDOZ GROUP AG Stock Sandoz Group AG
+16.41% 14.9B
CIPLA LIMITED Stock Cipla Limited
+9.03% 13.39B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+40.48% 12.12B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.68% 6.92B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.13% 5.47B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BQST Stock
  4. Financials BioQuest Corp.